For a typical FMCW automotive radar system, a new design of baseband signal processing architecture and algorithms is proposed to overcome the ghost targets and overlapping problems in the multi-target detection scenario. To satisfy the short measurement time constraint without increasing the RF front-end loading, a three-segment waveform with different slopes is utilized. By introducing a new pairing mechanism and a spatial filter design algorithm, the proposed detection architecture not only provides high accuracy and reliability, but also requires low pairing time and computational loading. This proposed baseband signal processing architecture and algorithms balance the performance and complexity, and are suitable to be implemented in a real automotive radar system. Field measurement results demonstrate that the proposed automotive radar signal processing system can perform well in a realistic application scenario.

Background. Undersampling of gliomas at first biopsy is a major clinical problem, as accurate grading determines all subsequent treatment. We submit a technological solution to reduce the problem of undersampling by estimating a marker of tumor proliferation (Ki-67) using MR imaging data as inputs, against a stereotactic histopathology gold standard. Methods. MR imaging was performed with anatomic, diffusion, permeability, and perfusion sequences, in untreated glioma patients in a prospective clinical trial. Stereotactic biopsies were harvested from each patient immediately prior to surgical resection. For each biopsy, an imaging description (23 parameters) was developed, and the Ki-67 index was recorded. Machine learning models were built to estimate Ki-67 from imaging inputs, and cross validation was undertaken to determine the error in estimates. The best model was used to generate graphical maps of Ki-67 estimates across the whole brain. Results. Fifty-two image-guided biopsies were collected from 23 evaluable patients. The random forest algorithm best modeled Ki-67 with 4 imaging inputs (T2-weighted, fractional anisotropy, cerebral blood flow, K trans ). It predicted the Ki-67 expression levels with a root mean square (RMS) error of 3.5% (R 2 = 0.75). A less accurate predictive result (RMS error 5.4%, R 2 = 0.50) was found using conventional imaging only. Conclusion. Ki-67 can be predicted to clinically useful accuracies using clinical imaging data. Advanced imaging (diffusion, perfusion, and permeability) improves predictive accuracy over conventional imaging alone. Ki-67 predictions, displayed as graphical maps, could be used to guide biopsy, resection, and/or radiation in the care of glioma patients. Key Points1. Proliferative activity in gliomas can be predicted with MRI to guide biopsy and therapy.2. Machine learning of clinical imaging data can be used to predict quantitative pathological markers. Gates et al. Guiding the first biopsy in glioma patientsNeuro-Oncology glioma patients. Further clinical trials are justified to verify and build on these findings.

No abstract